Market Research Trends

According to Future Market Insights' newly released Hospital-acquired Infection Control Market analysis report, global sales of Hospital-acquired Infection Control in 2023 are expected to be US$ 6.5 billion. The market is expected to reach US$ 12.7 billion by 2033, with a CAGR of 7% from 2023 to 2033. Hospitals and Intensive Care Units are predicted to create considerable revenue in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, the increasing proportion of surgical procedures, the growing geriatric population and the increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the growth of the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, are projected to increase demand for hospital-acquired infection management. Over t

According to market predictions, the global Opioid Use Disorder Treatment market revenue will be worth US$ 3.07 billion in 2023 and will grow at a CAGR of 10.5% during the forecast period, reaching US$ 8.4 billion by 2033. The providers and manufacturers of drug abuse therapy are primarily concerned with raising public and drug store owner knowledge of the dangers of drug misuse and the importance of obtaining treatment. This technique contributes to the expansion of the Opioid Use Disorder Treatment business by increasing their customer base. Various media, such as television commercials, newspapers, and information brochures, are being used effectively to raise awareness and combat the opioid epidemic. Collaborations between diverse organisations are also fueling the industry's growth. For example, GlaxoSmithKline collaborated with 2morrow Inc., the producer of the SmartQuit app, in March 2016 to deliver patches to smokers who adhered to the app's plan. Similarly, in August

The global Cerebral Aneurysm Management market sales is expected to be worth US$ 1.56 billion in 2023 and US$ 2.98 billion by 2023 to 2033, at a CAGR of 6.7%. The growing older population, as well as the availability of numerous treatments for the condition, may have contributed to the expansion of the Cerebral Aneurysm Management market. From 2018 to 2022, the market for Cerebral Aneurysm Management developed at a CAGR of 4%. The growing number of people with cerebrovascular illnesses worldwide is driving the expansion of the cerebral aneurysm therapy market. Factors such as an increase in high blood pressure patients, blood vessel injuries, and harmful lifestyle behaviours such as smoking all contribute to the market's growth. The growing use of medicinal therapy to treat unruptured cerebral aneurysms, advances in neurodegenerative disease drug development, and a rise in cigarette smokers are all factors. The market is being boosted by improved healthcare infrastructure, increas

According to a recent Future Market Insights report, the global Autosomal Dominant Polycystic Kidney Disease Treatment market demand will grow at a 5.97% CAGR from 2023 to 2033, reaching an estimated value of US$ 2,140 million. One of the primary drivers of market expansion is the availability of special regulatory designations, with an increase in Autosomal Dominant Polycystic Kidney Disease Treatment trials also projected to add to the industry's progress. Furthermore, regulatory authorities are expected to introduce and approve new Autosomal Dominant Polycystic Kidney Disease Treatment drugs, which will drive industry growth. Drug companies profit from market exclusivity for a set amount of time, as well as clinical trial tax benefits and treatment assistance, which helps to increase the market. Technological developments and the development of a wide range of medications are also projected to push market expansion, allowing physicians to better aid patients with Autosomal Domi

From 2023 to 2033, the global Venous Ulcer Treatment market revenue is expected to be worth US$ 2.96 billion, with a compound annual growth rate (CAGR) of 6.5%. By the end of the projected period, the market is expected to be worth US$ 7.61 billion. According to the NHS, venous ulcers are the most common cause of leg ulcers, accounting for more than 90% of all cases and affecting around 1 in 500 persons in the UK. The key factors driving market growth in the next years will be an increase in the incidence of venous ulcers and an increase in the deployment of compression treatment for venous leg ulcers. Increased awareness of the availability of therapeutic interventions for venous ulcers, as well as therapeutic breakthroughs, are projected to boost the Venous Ulcer Treatment market throughout the forecast period. North America will lead the worldwide Venous Ulcer Treatment industry in 2022. It is likely to lead the market over the forecast years. The European Venous Ulcer Treatment ma

According to a recently published Future Market Insights analysis, the global Urinary Retention Therapeutics market size is likely to reach an amazing valuation of USD 3.44 billion in 2023 and US$ 7.5 billion by 2033, with a CAGR of 8.11% till 2033. The increased prevalence of underactive bladder illnesses and rising cases of urinary incontinence disease are expected to drive the market. According to the American Urological Association 2017 report, more than 200 million people worldwide suffered from stress urinary incontinence condition in 2017, which can have a major impact on both men and women's quality of life. As a disease whose prevalence increases with age, it affects more women than men by a factor of 3:1. Increased healthcare spending, on the other hand, assists healthcare organisations and government authorities in increasing research and development activities on menopause medications, forthcoming clinical trials, and other research activities. Furthermore, due to the

The global Retinal Vein Occlusion Treatment market size is predicted to be worth US$ 2.3 billion in 2023, with a compound yearly growth rate (CAGR) of 5.9% to reach US$ 4.7 billion from 2023 to 2033. Retinal vein occlusion is one of the most common retinal vascular disorders in the elderly, affecting adults over the age of 65. Age is a key risk factor for retinal vein occlusion. The incidence of retinal vein blockage is projected to rise as the geriatric population grows. North America held a significant percentage of the global retinal vein occlusion market in 2022 due to numerous upgraded medical facilities, an increase in the occurrence of eye ailments, technological improvements, and an increase in the ageing population. The Asia Pacific retinal vein occlusion market is anticipated to grow at a 6.5% CAGR between 2023 and 2033. Rising ocular illness prevalence in Asia Pacific, particularly in China, Singapore, Indonesia, and other Southeast Asian countries, as well as rising health

According to Future Market Insights, the Low-grade Glioma Therapeutics market demand is predicted to develop at a 4.57% CAGR from 2023 to 2033. The global market for Low-grade Glioma Therapeutics is predicted to reach a market worth of US$ 1515.47 Million by 2033. The market's expansion can be ascribed to the increasing prevalence of low-grade glioma Therapeutics and the development of new medications to treat the disease. The market for low-grade glioma Therapeutics has expanded in recent years, owing to advances in cancer research as well as increased patient awareness and need for effective treatments. Surgery, radiation treatment, and chemotherapy are commonly used to treat low-grade gliomas. Despite these treatments, many patients experience disease recurrence, and the survival rate for low-grade gliomas remains poor. The increased demand for more effective Therapeutics for low-grade gliomas has resulted in the development of novel medications and therapies aimed specifically

The global Hypercoagulability Treatment market sales is expected to be worth US$ 670 million in 2023 and US$ 1,317.99 million by 2033, with a CAGR of 7% from 2023 to 2033. From 2018 to 2022, the market for Hypercoagulability Treatment increased at a CAGR of 4%. The growing awareness of hypercoagulability and its repercussions, as well as the increasing prevalence of illnesses that raise the risk of hypercoagulability, are propelling the hypercoagulability therapy market forward. The rising demand for these therapies is projected to spur the development of new and innovative treatments, propelling the industry forward in the coming years. Because of the increasing prevalence of hypercoagulability and the increased focus on developing treatment choices for patients, the market is expected to rise significantly. Various startups are entering the market as a result of positive growth. Novela Neurotechnology, for example, is a startup based in the United States that has created Neureka, a

The global Sandhoff Disease Therapeutics Market size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent research, Sandhoff illness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these therapies is projected to spur the development of new and innovative treatments, propelling the industry forward in the coming years. Sandhoff illness is being studied as a potential treatment with gene therapy. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to delay or stop disease progression while also improving the patient's quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2

According to Future Market Insights' recently published Surgical Snares Market analysis report, the global industry is expected to be worth approximately US$ 1.3 billion in 2022. The market is expected to grow at an 11.6% CAGR, reaching a global value of US$ 3.8 billion by the end of 2032. Throughout the forecast period, the global market is predicted to offer an absolute monetary potential of US$ 2.5 billion. Snare devices are essential equipment for a variety of surgical procedures. These instruments are utilised in many surgical procedures such as laparoscopy, urology, and gastrointestinal endoscopy. The market has developed considerably in recent years as the number of endoscopic treatments has increased. Every year, millions of individuals worldwide undergo surgery, according to a WHO report. These devices help with treatments such as ear, nose, and tonsil surgery. Furthermore, these devices aid in the removal of malignancies, increasing demand for snare devices. Furthermore,

Global x-ray device market sales expected to grow 7.5% year on year to $24.4 billion in 2032. The key causes driving the expansion of portable systems include advanced technology, an increasing number of patients with chronic diseases, an increasing senior population, and greater awareness about the availability of portable systems. Furthermore, the portable X-ray machine has the capability of transcending geographical boundaries and assisting patients in life-threatening situations who require quick care wherever they are, possibly necessitating an on-the-spot diagnosis. As a result, portable X-ray equipment is crucial in the diagnosis and monitoring of patients at their bedsides, eliminating the need for the patient to be carried to the X-ray room. Portable X-ray systems have several advantages over traditional X-ray systems. Within North America, the United States dominates the examined market and is expected to do so for the foreseeable future. The growing burden of chronic diseas

FMI just issued an industry analysis study on the Veterinary Hospitals Market . According to their results, global Veterinary Hospital sales will reach roughly US$ 74.9 billion in 2022, with a 6.2% expected market growth rate between 2022 and 2032, which is much higher than the historical average. From 2022 to 2032, private veterinary hospital applications are predicted to generate the most revenue, with a potential absolute dollar opportunity of around US$ 39.9 billion. The growing demand for meat and milk products, as well as the growing trend of pet ownership, have fueled the growth of the Veterinary Hospitals Market. Over 98 million dogs are kept as pets in the United States alone, with pets residing in approximately 68% of American households. Furthermore, pet ownership has surged by 56% in the United States since 1988. Pets require veterinarian care not only for emergency situations, but also for immunisations, neutering, and other treatments. This spike in pet culture has led in

The liposomal doxorubicin market is expected to grow at a 5.4% CAGR between 2022 and 2032. The lead mining software market is expected to grow from US$ 1,240 Million in 2022 to US$ 2.1 Billion by 2032. Because of changes in the working population's sedentary lifestyles and stressful schedules, the sales of liposomal doxorubicin pharmaceuticals are increasing, which is increasing the prevalence of these diseases and favourably boosting the liposomal doxorubicin market growth. Liposomal doxorubicin is in high demand since it is used to treat cancer, Kaposi Sarcoma, and a range of other disorders. Because of rising cancer incidence, the development of technologically complex drug delivery techniques, increased patient awareness, and rising disposable incomes, the global liposomal doxorubicin market share is predicted to grow. Following the failure of previous systemic treatment for ovarian cancer and AIDS-related Kaposi's sarcoma, liposomal doxorubicin sales are predicted to skyr

The global demand for interventional cardiology devices market is predicted to expand at an 8.4% CAGR from 2022 to 2032. The interventional cardiology equipment market is expected to be valued US$ 16.4 billion in 2022 and US$ 36.9 billion by 2032. The trajectory of interventional cardiology device adoption trends is rising as a result of the numerous advantages of minimally invasive surgeries, such as reduced surgical pain, injury, and shorter recovery time when compared to conventional surgeries, proving to be a viable alternative to open surgery. Demand for interventional cardiology devices is expected to drive the market throughout the projected period, owing to manufacturers' focus on major R&D to give important solutions to the healthcare sector. Diabetes is more likely to be linked to other conditions that raise the risk of coronary heart disease. Diabetes and hypertension are two additional risk factors driving the demand for interventional cardiology equipment. Accordi

The global vascular patches market is predicted to grow by 5.8% between 2021 and 2031, with a market value of around US$ 144.8 million in 2022. By 2031, the Vascular Patches market is anticipated to be worth US$ 241.4 million. Biologic vascular patches by materials represented a 52.9% share of the global market in 2020, according to Future Market Insights (FMI). The global prevalence of cardiovascular illnesses is increasing. The increased prevalence of heart illnesses will drive the market for vascular patches. Vascular patches have developed as a new revenue stream for biotech and pharmaceutical firms. Increasing technological breakthroughs in the cardiac therapeutic field have aided the widespread use of vascular patches for revascularization as an efficient technique of therapeutic use of vascular patches. The increased availability of high-quality patch products worldwide is addressing unmet requirements for cardiological therapy. Physical inactivity, nicotine usage and smoking,

The IoT in Healthcare market globally was valued at approximately US$ 181.4 Billion, and is projected to reach US$ 952.3 Billion by 2032, exhibiting an unprecedented CAGR of 18% between 2022 and 2032, according to market research. Self-health management is becoming increasingly popular worldwide, thanks to the widespread use of wearable medical devices that make it easier to monitor health concerns. Companies like Eversense and Dexcom have received FDA approval for their glucose monitoring devices, which can monitor sugar levels for up to three months. In addition, the Zoll LifeVest 4000 is a wearable defibrillator that can detect irregular heartbeats, or arrhythmias, in both children and adults, potentially preventing sudden cardiac arrest. AI, ML, and NLP technologies are assisting in patient health analysis. However, it is also important to note that security risks associated with IoT in healthcare cannot be ignored, which may limit the growth of the IoT in healthcare market. Futur

The global dental plaster market is estimated to be worth US$ 140.8 million in 2022 and to grow at a 5.4% CAGR to US$ 238.6 million by the end of 2032. According to Future Market Insights, the enhanced stone plaster (type IV) will dominate the global market in terms of product in 2021, with a market value share of approximately 30.7%. This is due to its wider adoption range and diverse spectrum of final dental cast goods. Dental plaster is a hemihydrate plaster (CaSO4.1/2H2O) composition. It is off white in appearance and made from naturally occurring mineral gypsum. It is widely employed in a variety of applications in dentistry, particularly in the fabrication of dentures. It can also be used in conjunction with dental stone plaster to create model dentures and working tray bases. The global prevalence of many orthodontic indications is expected to drive growth in the dental plaster market during the forecast period. The United States led the North America dental plasters market in

Global vascular patches market demand is expected to increase by 5.8% from 2021 to 2031, with a market value of around US$ 136.9 million in 2021. Vascular Patches market is expected to reach US$ 241.4 Million by 2031. According to Future Market Insights (FMI), biologic vascular patches by materials held a 52.9% share of the global market in 2020. There is a global increase in the prevalence of cardiovascular diseases. The rising prevalence of cardiac disorders will boost the vascular patches market. Vascular patches have emerged as a new avenue for revenue generation for biopharmaceutical and pharmaceutical companies. Increasing technological advancements within the cardiac therapeutic sphere have assisted the soaring adoption of vascular patches for revascularization as effective means for therapeutic usage of vascular patches. The unmet needs for cardiological treatments are addressed by the growing availability of high-quality patch products worldwide. Increasing lifestyle changes

The telemedicine equipment market was valued at more than US$ 3.5 billion in 2021, and it is predicted to grow at a 17.3% CAGR over the forecast period. The increasing incidence and prevalence of chronic diseases such as cancer and others are pushing the telemedicine equipment market. Furthermore, the growing number of people suffering from chronic diseases would have a beneficial impact on the Telemedicine equipment industry. As Telemonitoring and home telehealth advancements will be critical in increasing telemedicine adoption among the general population. Furthermore, advances in telemedicine software and enhanced healthcare facilities are expected to drive growth in the telemedicine equipment market during the forecast period. Furthermore, increased telemedicine equipment quality would increase market demand. The North American telemedicine equipment market is anticipated to be worth USD 2,263.0 million in 2021, with a 16.7% CAGR during the forecast period. Local governments impos

The global flexible endoscopes market is predicted to increase at a 6.4% CAGR to US$ 16.73 billion by 2033, up from US$ 8.44 billion in 2022. The increased demand for flexible endoscopes used in gastrointestinal investigations is expected to drive market growth significantly. Globally, the standard of living has risen, leading to increasing spending on medical services and infrastructure. As a result of the widespread growth of chronic diseases, people are becoming more aware of the need of routine check-ups and the need to be diagnosed for the presence of any sickness. Flexible endoscopes have become an essential tool for inspecting gastrointestinal tracts for signs of illness. The growing popularity of this type of diagnosis, particularly among these countries' senior populations, is driving the global market in developed economies. The newly developed flexible endoscopy techniques, which are predicted to enhance the adoption rate of flexible endoscopes, allow for a clearer view

The global stoma/ostomy care market is projected to reach a value of US$ 3.8 billion by the end of 2022, and is expected to grow at a compound annual growth rate (CAGR) of 4.9% during the forecast period from 2023 to 2033, reaching a market value of approximately US$ 6.5 billion by 2033. The growth of the stoma care market is attributed to factors such as the increasing prevalence of diseases requiring ostomy care, advancements in surgical techniques and ostomy products, greater awareness, and reimbursements. The most common diseases requiring ostomy care are colorectal cancer, bladder cancer, and inflammatory bowel disease, which are treated with surgical excision of aggressive melanoma of the intestine (IBD). In some cases, an ostomy is required, which involves making a surgical incision through the abdomen to create a new waste minimization conduit. The adoption of stoma/ostomy care procedures has increased worldwide due to the rising occurrence of these diseases and increased expo

The IV poles market is projected to reach a value of US$ 306.1 Million by 2029, registering a 3.6% CAGR from 2022 to 2029. The market is expected to achieve an estimated worth of US$ 238.4 Million in 2022, driven by a surge in chronic illnesses, a rapid rise in the aging population, and an increase in hospital beds to cater to the growing number of patients. The global IV poles industry is also likely to benefit from the escalating healthcare expenditure during the forecast period. The mounting number of hospitals globally, coupled with the burgeoning healthcare costs, has opened up new prospects for the IV poles sector. The surge in hospital beds has triggered an upswing in the application of IV poles for various purposes in hospitals and clinics, thereby propelling the growth of the IV poles market from 2022 to 2029. Moreover, technological advancements, the prevalence of chronic diseases, and an emphasis on hospital infrastructure development are bolstering the adoption of IV poles

According to Future Market Insights (FMI), the Global Pressure Infusion Bags Market was valued at around US$ 318.6 Million in 2022 and is predicted to reach US$ 494.5 Million by 2029, with a CAGR of 6.5%. This growth is majorly driven by the increasing use of pressure infusion bags for rapid infusion of blood and drugs, in order to protect the end organ damage during traumatic conditions. South Asia Continues to Hold Lucrative Opportunities Regions such as North America and East Asia are expected to hold prominent market shares in terms of value. However, the South Asia market is expected to project lucrative growth in the global pressure infusion bags market over the forecast period of 2022 to 2029. This growth is propelled by the rapid growth and development of healthcare infrastructure, especially trauma care units, intensive care units and ambulatory surgical centers in countries of South Asia that include India and ASEAN countries. The economic condition of these countries have b

The global female stress urinary incontinence treatment devices market is now valued at US$ 702.4 million and is predicted to grow at a high CAGR of 6.2% (2022 to 2029) to reach US$ 1.07 billion by the end of 2029. In 2021, female stress urinary incontinence treatment device sales were worth 20.5% of the global urine incontinence treatment device market. Female stress urinary incontinence treatment device shipments are likely to rise in the future as knowledge of the problem grows through government initiatives around the world. Several regulatory and device factors, as well as industry and macroeconomic criteria, will have an impact on the market. Key market advancements include the introduction of intravaginal devices and radiofrequency treatment for the treatment of female stress urine incontinence. Because of the disease's increasing global incidence, there has been a surge in the acceptance of female stress urinary incontinence treatment devices in recent years. The amount of

The global peripheral intravenous catheters market is expected to grow steadily at a rate of 7.2% YoY, reaching a valuation of US$ 11.03 billion by 2032. The increasing acceptance of catheterisation techniques for diagnosis, examination, and treatment of patients is projected to drive the demand for PIVC. The North American market is likely to remain the largest market, while the Asia Pacific market is expected to grow at the fastest pace. The rising incidence of diseases is a significant factor driving the demand for catheterisation and PIVC. Besides drug administration, the use of PIVC in body fluid collection during physical examinations is also identified as a key driver of market growth. The prevalence of infections and epidemics is expected to further increase demand for catheters across hospitals, clinics, ambulatory surgical centers, home healthcare units, and other healthcare facilities. Increasing investments in healthcare infrastructure, as well as rising healthcare spendin

By the end of 2022, the global radio frequency beauty equipment market is projected to be valued at US$ 339.9 million, and is expected to reach a valuation of US$ 1.8 billion by the end of 2032 with a CAGR of 17.9%. As per a recent report by Future Market Insights, body contouring is expected to dominate the global market in 2021, accounting for a market share of about 50.5%. The demand for radio frequency beauty equipment is rapidly increasing due to the adoption of new technologies that serve as effective alternatives to traditional methods. The production of radio frequency beauty equipment is expected to increase globally due to their high demand in both developed and developing markets. The United States is the leading country in the North American region, with a market share of approximately 80.9% in 2021, and is expected to grow at a CAGR of 16.7% during the forecast period. The expansion of the healthcare industry in the United States is expected to drive the growth of the rad

The global  portable oxygen concentrators market  is anticipated to witness lucrative growth opportunities over the forecast period from 2022 and 2032, with a phenomenal CAGR of 10.1%. The market is expected to enjoy a valuation of US$ 1.9 Billion by the end of the year 2022 and surpass a projection of US$ 5.0 Billion by the year 2032. According to the Future Market Insights historical analysis, the pulse flows portable oxygen concentrators were leading the market with a share of about 67.7% in the year 2021, within the global market. In the year 2021, the market value for portable oxygen concentrators was around 54.8% of the overall US$ 3.5 Billion of the global oxygen concentrators market. Portable oxygen concentrators supply oxygen to those patients who are suffering from respiratory diseases such as chronic obstructive pulmonary disease. In this process, nitrogen and oxygen are separated from the air in the environment with the help of the concentrator which then discards the nitro